News

All Categories

10 February 2015

Vaxxas raises $25m in Series B financing

Uncategorized

10 February 2015

Painful needles could one day be a thing of the past as Queensland’s Nanopatch gets financial injection

Uncategorized

17 November 2014

Replacing vaccine needles with tens of thousands of drug-laced pins that won’t hurt a bit

Uncategorized

13 October 2014

Professor Mark Kendall: Team Brisbane

Uncategorized

16 September 2014

Polio vaccine: Brisbane company Vaxxas teams up with WHO to trial Nanopatch needle-free delivery system

Uncategorized

26 August 2014

Vaxxas selected as World Economic Forum Technology Pioneer 2015

Awards

26 August 2014

Vaxxas Selected as World Economic Forum Technology Pioneer 2015

Awards, Media Release

12 June 2013

Vaccines via a patch: Mark Kendall at TEDGlobal 2013

Uncategorized

17 March 2013

Vaxxas recogniseds as 2013 BioSpectrum Asia-Pacific Emerging Company of the Year

Awards

30 October 2012

Vaxxas recognised as Janssen Ausbiotech Emergeing Company of the Year 2012

Awards

08 October 2012

Vaxxas Appoints David Hoey as Company’s First CEO

Media Release

08 October 2012

Vaxxas Initiates Program With Merck to Optimize Delivery of Next Generation Vaccines Utilizing Novel Mechanism for Immune System Activation

Media Release

17 April 2012

Best Venture Capital Investment at the 2012 Vaccine Industry Excellence Awards

Awards, Media Release

09 February 2012

Vaxxas featured in BRW Top 10 start ups to watch

Awards

08 December 2011

Vaxxas wins Australian Innovation Challenge Awards

Awards

20 September 2010

Vaxxas wins Australian Research Council Eureka Prize

Awards

decor decor decor
decor decor decor decor decor